Q2 2024 |
69 |
$214M |
+$37.1M |
-$8.57M |
+$28.5M |
NVDA, SMCI, META, XOM, TTD
|
13F-HR |
8/6/2024, 11:36 AM |
Q1 2024 |
70 |
$207M |
+$37.7M |
-$37.1M |
+$614K |
NVDA, SMCI, META, XOM, CELH
|
13F-HR |
5/9/2024, 11:05 AM |
Q4 2023 |
79 |
$173M |
+$10.8M |
-$9.18M |
+$1.64M |
NVDA, XOM, META, AAPL, TSLA
|
13F-HR |
2/14/2024, 10:45 AM |
Q3 2023 |
83 |
$161M |
+$7.66M |
-$7.78M |
-$114K |
XOM, NVDA, TSLA, META, AAPL
|
13F-HR |
11/13/2023, 07:35 AM |
Q2 2023 |
79 |
$164M |
+$15.4M |
-$12.6M |
+$2.82M |
XOM, NVDA, TSLA, AAPL, META
|
13F-HR |
8/3/2023, 07:18 PM |
Q1 2023 |
77 |
$139M |
+$38.2M |
-$34.1M |
+$4.1M |
XOM, AAPL, AMLP, NVDA, INMD
|
13F-HR |
5/10/2023, 05:43 PM |
Q4 2022 |
67 |
$134M |
$0 |
$0 |
|
XOM, AMLP, LMT, EOG, COR
|
13F-HR |
2/14/2023, 01:43 PM |